Andrew Astor's most recent trade in Nephros Inc was a trade of 14,815 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on March 5, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nephros Inc | Andrew Astor | Director, President, CEO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. | 05 Mar 2022 | 14,815 | 92,773 (1%) | 0% | 2.7 | 40,001 | Common Stock |
| Nephros Inc | Andrew Astor | Director, President, CEO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2022 | 14,815 | 0 | - | - | Warrants (right to buy) | |
| Nephros Inc | Andrew Astor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 38,612 | 38,612 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Andrew Astor | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 17 Aug 2021 | 2,500 | 75,458 (0%) | 0% | 7.7 | 19,172 | Common Stock |
| Nephros Inc | Andrew Astor | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 17 Aug 2021 | 2,500 | 77,958 (0%) | 0% | 7.8 | 19,433 | Common Stock |
| Nephros Inc | Andrew Astor | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 5.87 per share. | 19 Nov 2020 | 1,000 | 72,958 (0%) | 0% | 5.9 | 5,867 | Common Stock |